MDT

86.38

+0.14%↑

A

113.77

-0.97%↓

VEEV

172.52

-1.27%↓

HQY

80.96

-2.52%↓

PHR.US

9.06

+0.33%↑

MDT

86.38

+0.14%↑

A

113.77

-0.97%↓

VEEV

172.52

-1.27%↓

HQY

80.96

-2.52%↓

PHR.US

9.06

+0.33%↑

MDT

86.38

+0.14%↑

A

113.77

-0.97%↓

VEEV

172.52

-1.27%↓

HQY

80.96

-2.52%↓

PHR.US

9.06

+0.33%↑

MDT

86.38

+0.14%↑

A

113.77

-0.97%↓

VEEV

172.52

-1.27%↓

HQY

80.96

-2.52%↓

PHR.US

9.06

+0.33%↑

MDT

86.38

+0.14%↑

A

113.77

-0.97%↓

VEEV

172.52

-1.27%↓

HQY

80.96

-2.52%↓

PHR.US

9.06

+0.33%↑

Search

Simulations Plus Inc

Cerrado

SectorSanidad

12.61 1.2

Resumen

Variación precio

24h

Actual

Mínimo

12.02

Máximo

12.68

Métricas clave

By Trading Economics

Ingresos

1.4M

676K

Ventas

961K

18M

Rentabilidad por dividendo

0.48

Margen de beneficios

3.67

Empleados

212

EBITDA

-3M

2.3M

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 Meses

+52.49% upside

Dividendos

By Dow Jones

Rentabilidad por dividendo

Media del Sector

0.48%

2.45%

Próximas Ganancias

9 abr 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

-117M

251M

Apertura anterior

11.41

Cierre anterior

12.61

Noticias sobre sentimiento de mercado

By Acuity

37%

63%

111 / 349 Clasificación en Healthcare

Simulations Plus Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

7 abr 2026, 17:26 UTC

Noticias de Eventos Importantes

EIA Raises Oil-Price Forecasts as War in Middle East Continues

7 abr 2026, 23:55 UTC

Charlas de Mercado

Genesis Energy Signals Higher Dividend Payout Ratios -- Market Talk

7 abr 2026, 23:47 UTC

Charlas de Mercado
Noticias de Eventos Importantes

Market Talk Roundup: Latest on U.S. Politics

7 abr 2026, 23:47 UTC

Charlas de Mercado
Noticias de Eventos Importantes

Precious Metals Rise, Boosted by Dollar Weakness, Lower Treasury Yields -- Market Talk

7 abr 2026, 23:44 UTC

Charlas de Mercado
Noticias de Eventos Importantes

Gold Rallies as Trump Remarks Send Oil Prices Lower -- Market Talk

7 abr 2026, 23:42 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

7 abr 2026, 23:42 UTC

Charlas de Mercado

Nikkei Likely to Rise After Trump Agrees to Cease-Fire With Iran -- Market Talk

7 abr 2026, 23:37 UTC

Charlas de Mercado
Noticias de Eventos Importantes

Oil Futures Fall After Trump Agrees to Two-Week Cease-Fire With Iran -- Market Talk

7 abr 2026, 23:15 UTC

Charlas de Mercado
Noticias de Eventos Importantes

Markets Will Want Fast Evidence That Ships Are Moving -- Market Talk

7 abr 2026, 23:04 UTC

Noticias de Eventos Importantes

Spot Gold Rises 2.5%, Spot Silver Climbs 4.9%

7 abr 2026, 23:04 UTC

Noticias de Eventos Importantes

Precious Metals Rise After Trump Agrees to Ceasefire With Iran

7 abr 2026, 23:03 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

7 abr 2026, 23:03 UTC

Charlas de Mercado

Middle East Ceasefire Triggers Australian Dollar Rally -- Market Talk

7 abr 2026, 23:01 UTC

Noticias de Eventos Importantes

Front-Month WTI Crude Oil Futures Falls 13.7% to $97.47 per Barrel

7 abr 2026, 22:58 UTC

Noticias de Eventos Importantes

Front-Month Crude Oil Futures Slide After Trump Agrees to Cease-Fire With Iran

7 abr 2026, 21:56 UTC

Adquisiciones, fusiones, absorciones

Telefónica Sells All Shares in Pegaso PCS, Celular de Telefonía

7 abr 2026, 20:50 UTC

Charlas de Mercado
Noticias de Eventos Importantes

Basic Materials Roundup: Market Talk

7 abr 2026, 20:15 UTC

Charlas de Mercado

Global Commodities Roundup: Market Talk

7 abr 2026, 19:45 UTC

Charlas de Mercado

Treasury Yields Mixed as Investors Brace for Iran Deadline -- Market Talk

7 abr 2026, 19:17 UTC

Noticias de Eventos Importantes

The Risks to the Gulf Region's Oil Are Immense. Are Markets Shrugging Them Off? -- Barrons.com

7 abr 2026, 19:16 UTC

Charlas de Mercado

Cold Shot Helps U.S. Natural Gas Futures Settle Higher -- Market Talk

7 abr 2026, 19:07 UTC

Charlas de Mercado

Global Energy Roundup: Market Talk

7 abr 2026, 19:07 UTC

Charlas de Mercado

Oil Futures Mixed Ahead of Trump's Iran Deadline -- Market Talk

7 abr 2026, 18:41 UTC

Adquisiciones, fusiones, absorciones

Eldorado Gold: Total of 149.6M Common Shrs, Representing 75.31% of Votes Attached to All Outstanding Common Shrs, Were Voted >ELD.T

7 abr 2026, 18:40 UTC

Adquisiciones, fusiones, absorciones

Eldorado Gold Holders Voted to Approve Issuance of Common Shrs in Connection With Proposed Plan of Arrangement With Foran Mining >ELD.T

7 abr 2026, 18:39 UTC

Adquisiciones, fusiones, absorciones

Eldorado Gold Reports Voting Results From Special Meeting of Hldrs

7 abr 2026, 18:24 UTC

Noticias de Eventos Importantes

Defense Stocks Can't Get a Boost From Iran War Escalations. What Would Move Them. -- Barrons.com

7 abr 2026, 17:08 UTC

Charlas de Mercado

Latin America Less Exposed to Crude Supply Disruptions -- Market Talk

7 abr 2026, 16:21 UTC

Noticias de Eventos Importantes

Defense Stocks Can't Get a Boost From Iran War Escalations. What Would Move Them. -- Barrons.com

7 abr 2026, 16:20 UTC

Charlas de Mercado
Adquisiciones, fusiones, absorciones

Health Care Roundup: Market Talk

Comparación entre iguales

Cambio de precio

Simulations Plus Inc previsión

Precio Objetivo

By TipRanks

52.49% repunte

Estimación a 12 Meses

Media 19 USD  52.49%

Máximo 19 USD

Mínimo 19 USD

De acuerdo con 4 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Simulations Plus Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

4 ratings

2

Comprar

2

Mantener

0

Vender

Sentimiento

By Acuity

111 / 349 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Coyuntura alcista

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Simulations Plus Inc

Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through Software and Services segments. It also offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products. In addition, the company provides products based on mechanistic and mathematical models, such as DILIsym, NAFLDsym, ILDsym, IPFsym, RENAsym, MITOsym, and OBESITYsym products. Further, it offers Absorption, Distribution, Metabolism, Excretion, and Toxicity Predictor for chemistry-based computer program that takes molecular structures as inputs and predicts their properties; and MedChem Designer, as well as MonolixSuite products for modeling and simulation that allows for population analyses, rapid clinical trial data analyses, and regulatory submissions. Additionally, the company provides clinical-pharmacology-based consulting services, which includes population pharmacokinetic and pharmacodynamic modeling, exposure-response analyses, clinical trial simulations, data programming, and technical writing services in support of regulatory submissions; and early drug discovery services. Furthermore, it offers creative and insightful consulting services to support its quantitative systems pharmacology and other modeling systems. The company serves pharmaceutical, biotechnology, agrochemical, cosmetics, and food industry companies, as well as academic and regulatory agencies. Simulations Plus, Inc. was incorporated in 1996 and is headquartered in Lancaster, California.
help-icon Live chat